Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, and Weill Cornell Medicine have entered into ...

Blood-based proteomic profiling of 251 inflammatory proteins in 543 newly diagnosed patients with acute myeloid leukemia (AML) identified an eight-protein signature that enhances risk stratification.

Evaluation of market's 15 preeminent AML solutions finds SAS Anti-Money Laundering a great fit for firms that need "cutting-edge, AI/ML risk-scoring strategies for highly efficient AML processes" CARY ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Validation cohorts comprised 68 patients consecutive newly diagnosed AML from the same institution ... the European LeukemiaNet (ELN) 2022 risk model and was independently prognostic of overall ...